# Suleyman Demirel University

Organization · id `cardio:org-suleyman-demirel-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Suleyman+Demirel+University>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Suleyman Demirel University
- Sponsor class: OTHER

## Connected pages

- Sponsors: Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention (`cardio:ct-nct01878344`)
- Sponsors: Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention (`cardio:ct-nct01878669`)
- Sponsors: Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation (`cardio:ct-nct01924065`)

## Provenance

Content hash: c731f88cfd944ff774764b8042a7d07e8812fcea5aca09675d1fc1da28884a77
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
